Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4529244?pdf=render |
Similar Items
-
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
by: Dominique L Braun, et al.
Published: (2015-01-01) -
Passive and active targeting of silibinin-loaded nanocarriers for treating hepatic fibrosis
by: You-Shan Dai, et al.
Published: (2016) -
HIV and Hepatitis C Virus Coinfection, Cameroon
by: Christian Laurent, et al.
Published: (2007-03-01) -
Detecting spatial clusters of HIV and hepatitis coinfections.
by: Suparna Das, et al.
Published: (2018-01-01) -
The epidemiology of hepatitis C and HCV-HIV coinfection
by: Mohsen, Abdul Hadi
Published: (2005)